• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Cancer Markers

$2,000.00 – $4,000.00

Clear
SKU: KLI5948135 Categories: Diagnostics Market Research, Oncology & Hematology Market Reports Pages: 155
  • Description
  • Table of Contents
  • Latest reports

Description

Cancer Markers

Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays – tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy.

Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow, rapid, molecular); global cancer biomarkers diagnostic market percentage (IHC, ISH, flow cytometry, molecular-based assays, NMP22, FOB, PSA, CEA, CA125, AFP, other tumor markers); selected extensively used tumor markers; selected biomarkers and biomarker panels to determine risk of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for cancer screening, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for diagnosis and/or monitoring of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict prognosis of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict response to therapy, and manufacturers developing/marketing these biomarkers; selected FDA-cleared/approved companion diagnostic tests, and manufacturers developing/marketing these biomarkers; selected manufacturers developing/marketing cancer tests; common next generation molecular test traits; selected sample preparation reagents; and selected cancer test innovations, 2015. Abbott Laboratories, Alere Inc., bioMérieux SA, Hologic, Inc., Illumina, Inc., QIAGEN N.V., Roche, and Thermo Fisher Scientific, Inc. are among the manufacturers discussed in the competitive analysis.

Table of Contents

ONE: EXECUTIVE SUMMARY

Market

Scope and Methodology

TWO: INTRODUCTION

Cancer Risk Assessment

Cancer Screening

Cancer Monitoring

Cancer Prognosis Assessment

Personalized Medicine/Precision Testing

Competition in Cancer Biomarkers

Molecular Markers

Precision Medicine

THREE: CANCER MARKERS MARKET ANALYSIS

FOUR: COMPANY PROFILES

20/20 GeneSystems, Inc

Abbott Laboratories

Recent Revenue History

Agreements

Abcodia Ltd.

Financings

Alere Inc. (Abbott)

Ambry Genetics Corp.

Asuragen, Inc.

Diagnostic Products

Translational/Companion Diagnostics

Agreements

Athena Diagnostics, Inc. (A Quest Diagnostics Business)

bioMérieux SA

Recent Revenue History

Company Overview

Immunodiagnostics for Lab Professionals (Clinical Laboratories)

Molecular Diagnostics

bioTheranostics, Inc. (A bioMérieux Company)

Cancer Genetics, Inc.

Recent Revenue History

Company Overview

Agreements

Genomic Health, Inc.

Recent Revenue History

Genoptix (A Novartis Company)

Hologic, Inc.

Recent Revenue History

Company Overview

Illumina, Inc.

Recent Revenue History

Company Overview

Myriad Genetics, Inc.

Recent Revenue History

Company Overview

QIAGEN N.V.

Recent Revenue History

Roche

Recent Revenue History

Company Overview

Roche Professional Diagnostics

Molecular Diagnostics

Tissue Diagnostics

Thermo Fisher Scientific, Inc.

Recent Revenue History

Company Overview

Wako Pure Chemical Industries, Ltd.,

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

Figure 1-1: Cases of Cancer by Type

Figure 1-2: Cancer Marker-Based Test Market, 2015 and 2020

TWO: INTRODUCTION

Table 2-1: Estimated Global Incidence and Mortality due to Cancer, 2012 – By Regionsnof the World

Table 2-2: Selected Widely Used Tumor Markers

Table 2-3: Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer, and Companies Developing/Marketing These Biomarkers

Table 2-4: Selected Biomarkers and Biomarker Panels for Cancer Screening, and Companies Developing/Marketing These Biomarkers

Table 2-5: Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer, and Companies Developing/Marketing These Biomarkers

Table 2-6: Selected Biomarkers and Biomarker Panels to Predict Prognosis of Cancer,and Companies Developing/Marketing These Biomarkers

Table 2-7: Selected Biomarkers and Biomarker Panels to Predict Response to Therapy,and Companies Developing/Marketing These Biomarkers

Table 2-8: Selected FDA Cleared/Approved Companion Diagnostic Tests, and Companies Developing/Marketing These Biomarkers

Table 2-9: Selected Companies Developing/Marketing Cancer Tests

Table 2-10: Common Next Generation Molecular Test Traits

Table 2-11: Selected Sample Preparation Reagents

Table 2-12: Selected Cancer Test Innovations, 2015

THREE: CANCER MARKERS MARKET ANALYSIS

Table 3-1: Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020 (IHC,ISH, Immunoassays, Flow, Rapid, Molecular)

Table 3-2: Selected International Agreements

Figure 3-1: Worldwide Cancer Biomarkers Diagnostic Market Percentage (IHC, ISH,Flow Cytometry, Molecular-Based Assays, NMP22, FOB, PSA, CEA, CA125, AFP,Other Tumor Markers)

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Market and Potential for Molecular Point of Care Diagnostics: Revenue Forecasts...Vaccines 2016-2022: World Market Analysis, Key Players, Trends, Pediatric and...
Scroll to top